“…It ranges from glycopeptide analysis, which provides information about site-specific glycosylation, to complete intact glycoprotein analysis, which provides intuitive information on the degree of glycosylation of the whole protein [ 31 , 32 , 49 , 50 , 51 ]. In particular, glycoproteomic analysis at the glycopeptide level is an effective method that can simultaneously acquire information on glycans and glycosylation sites [ 52 , 53 , 54 ], but it is not utilized in clinics due to the time required for the sample preparation step, difficulties of tandem MS analysis, and complex data interpretation. Therefore, there is a need for an easy and fast glycoproteomic analysis tool that can be used in the clinical field [ 7 ].…”